DEMENTIA
Clinical trials for DEMENTIA explained in plain language.
Never miss a new study
Get alerted when new DEMENTIA trials appear
Sign up with your email to follow new studies for DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Alzheimer's drug trial halted: Anti-Tau antibody fails to show promise
Disease control TerminatedThis study tested an experimental drug called JNJ-63733657, designed to target tau protein tangles in the brain, in people with early Alzheimer's disease. The goal was to see if it could slow down memory and thinking decline compared to a placebo. The trial was stopped early (ter…
Matched conditions: DEMENTIA
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Alzheimer's drug safety study ends early
Disease control TerminatedThis study looked at the long-term safety and effects of a drug called XPro1595 in people with Alzheimer's disease who had already taken it in earlier studies. Only 11 people took part, and the study was stopped early. The main goal was to check for side effects and see if the dr…
Matched conditions: DEMENTIA
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Eye test may spot Alzheimer's early
Diagnosis TerminatedThis study explored whether a special eye scan (hyperspectral retinal imaging) can detect beta-amyloid, a protein linked to Alzheimer's disease, in the retina. Researchers aimed to see if this non-invasive test could distinguish people with Alzheimer's from healthy individuals. T…
Matched conditions: DEMENTIA
Phase: NA • Sponsor: Center for Eye Research Australia • Aim: Diagnosis
Last updated May 17, 2026 06:51 UTC
-
Swallow-Scanner fails key test, study halted
Diagnosis TerminatedThis study tested a device called the Dysphagia Detection System (DDS) to see if it could accurately detect swallowing problems in people with conditions like stroke, Parkinson's disease, multiple sclerosis, Alzheimer's, or dementia. The device was compared to a standard X-ray te…
Matched conditions: DEMENTIA
Phase: NA • Sponsor: Société des Produits Nestlé (SPN) • Aim: Diagnosis
Last updated May 11, 2026 20:46 UTC
-
At-Home brain zaps aim to boost memory in dementia patients
Symptom relief TerminatedThis study tested whether a gentle, non-invasive brain stimulation technique called tDCS, done at home, could improve thinking and language skills in people with primary progressive aphasia, mild cognitive impairment, or dementia. Participants used a headset to stimulate a key br…
Matched conditions: DEMENTIA
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated May 11, 2026 20:51 UTC